Module232025

07/05/2025

References

11. Patel, A et al (2023) Availability of safe and effective therapeutic options to pregnant and lactating individuals following the US FDA Pregnancy and Lactation Labelling Rule. J.Pediatr., 259: 113342 12. Jacobson, M.H. (2024) Understanding willingness and barriers to participate in clinical trials during pregnancy and lactation: findings from a US study. BMC Pregnancy and Childbirth 24:504-517. 13. Feijoo, F (2020) Key indicators of phase transition for clinical trials through machine learning. Drug Discovery Today 25: 414-421 14. Turner, M.A (2015). Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and

conduct. Br J Clin Pharmacol., 79:370–378 15. List of youngest birth mothers, available at https://www.bionity.com/en/encyclopedia/List_of_youngest_birth_mothers.html

43